S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Russia accused of 'kidnapping' head of Ukraine nuclear plant
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
Danish Energy Agency says Nord Stream 2 gas pipeline under Baltic Sea appears to have stopped leaking gas
India launches 5G services, Modi calls it step in new era
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)
UK train strikes and energy hikes add to a week of turmoil
NIH to fund unproven ALS drugs under patient-backed law
NYSE:DLB

Dolby Laboratories - DLB Stock Forecast, Price & News

$65.15
-0.54 (-0.82%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$65.04
$66.60
50-Day Range
$65.15
$80.75
52-Week Range
$65.04
$96.85
Volume
374,549 shs
Average Volume
424,974 shs
Market Capitalization
$6.57 billion
P/E Ratio
33.58
Dividend Yield
1.52%
Price Target
$90.00

Dolby Laboratories MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
38.1% Upside
$90.00 Price Target
Short Interest
Healthy
1.71% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-0.42
Upright™ Environmental Score
News Sentiment
-0.12mentions of Dolby Laboratories in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.42 M Sold Last Quarter
Proj. Earnings Growth
16.53%
From $2.36 to $2.75 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.89 out of 5 stars

Consumer Discretionary Sector

35th out of 282 stocks

Patent Owners & Lessors Industry

3rd out of 6 stocks

DLB stock logo

About Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

Receive DLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.

DLB Stock News Headlines

Dolby Laboratories Inc - Ordinary Shares - Class A
Dolby Laboratories, Inc. (DLB)
Dolby Laboratories (NYSE:DLB) Issues Q4 2022 Earnings Guidance
Dolby Laboratories
Dolby (DLB) Q3 Earnings Beat Estimates, Revenues Up Y/Y
Dolby Laboratories Inc
Dolby Laboratories (DLB) Beats Q3 Earnings Estimates
See More Headlines
Receive DLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.

DLB Company Calendar

Last Earnings
8/09/2022
Ex-Dividend for 8/31 Dividend
8/22/2022
Dividend Payable
8/31/2022
Today
10/01/2022
Next Earnings (Estimated)
11/15/2022
Fiscal Year End
9/30/2023

Industry, Sector and Symbol

Industry
Patent owners & lessors
Sub-Industry
Electronic Components
CUSIP
25659T10
Employees
2,368
Year Founded
1965

Price Target and Rating

Average Stock Price Forecast
$90.00
High Stock Price Forecast
$90.00
Low Stock Price Forecast
$90.00
Forecasted Upside/Downside
+38.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$310.23 million
Pretax Margin
18.04%

Debt

Sales & Book Value

Annual Sales
$1.28 billion
Cash Flow
$4.25 per share
Book Value
$25.74 per share

Miscellaneous

Free Float
63,503,000
Market Cap
$6.57 billion
Optionable
Optionable
Beta
0.98

Social Links


Key Executives

  • Mr. Kevin J. YeamanMr. Kevin J. Yeaman (Age 56)
    Pres, CEO & Director
    Comp: $1.91M
  • Mr. Andy Sherman (Age 55)
    Exec. VP, Gen. Counsel & Corp. Sec.
    Comp: $954.04k
  • Mr. Todd PendletonMr. Todd Pendleton (Age 49)
    Sr. VP & Chief Marketing Officer
    Comp: $929.76k
  • Mr. Giles BakerMr. Giles Baker (Age 45)
    Sr. VP of Cloud Media Solutions
    Comp: $927.33k
  • Mr. Robert J. Park (Age 52)
    Sr. VP & CFO
  • Mr. Ryan NicholsonMr. Ryan Nicholson
    VP & Corp. Controller
  • Mr. Craig Todd
    CTO & Sr. VP
  • Ms. Maggie O'Donnell
    Head of Investor Relations
  • Ms. Linda Rogers
    Sr. VP & Chief People Officer
  • Mr. Ioan Allen
    Sr. VP













DLB Stock - Frequently Asked Questions

Should I buy or sell Dolby Laboratories stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dolby Laboratories in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DLB shares.
View DLB analyst ratings
or view top-rated stocks.

What is Dolby Laboratories' stock price forecast for 2022?

3 brokerages have issued twelve-month price targets for Dolby Laboratories' stock. Their DLB share price forecasts range from $90.00 to $90.00. On average, they predict the company's share price to reach $90.00 in the next twelve months. This suggests a possible upside of 38.1% from the stock's current price.
View analysts price targets for DLB
or view top-rated stocks among Wall Street analysts.

How have DLB shares performed in 2022?

Dolby Laboratories' stock was trading at $95.22 on January 1st, 2022. Since then, DLB shares have decreased by 31.6% and is now trading at $65.15.
View the best growth stocks for 2022 here
.

Are investors shorting Dolby Laboratories?

Dolby Laboratories saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 1,040,000 shares, an increase of 11.9% from the August 31st total of 929,600 shares. Based on an average trading volume of 438,200 shares, the short-interest ratio is presently 2.4 days. Currently, 1.7% of the shares of the stock are sold short.
View Dolby Laboratories' Short Interest
.

When is Dolby Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 15th 2022.
View our DLB earnings forecast
.

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories, Inc. (NYSE:DLB) announced its quarterly earnings data on Tuesday, August, 9th. The electronics maker reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.05. The electronics maker earned $289.60 million during the quarter, compared to analysts' expectations of $294.03 million. Dolby Laboratories had a net margin of 15.91% and a trailing twelve-month return on equity of 9.38%. The business's revenue was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.52 EPS.

How often does Dolby Laboratories pay dividends? What is the dividend yield for Dolby Laboratories?

Dolby Laboratories announced a quarterly dividend on Tuesday, August 9th. Investors of record on Tuesday, August 23rd will be given a dividend of $0.25 per share on Wednesday, August 31st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date of this dividend is Monday, August 22nd.
Read our dividend analysis for DLB
.

Is Dolby Laboratories a good dividend stock?

Dolby Laboratories (NYSE:DLB) pays an annual dividend of $1.00 per share and currently has a dividend yield of 1.52%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 51.55%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DLB will have a dividend payout ratio of 36.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DLB.

What guidance has Dolby Laboratories issued on next quarter's earnings?

Dolby Laboratories updated its fourth quarter 2022 earnings guidance on Tuesday, September, 13th. The company provided EPS guidance of $0.68-$0.83 for the period, compared to the consensus earnings per share estimate of $0.87. The company issued revenue guidance of $295.00 million-$325.00 million, compared to the consensus revenue estimate of $326.80 million.

What is Kevin J. Yeaman's approval rating as Dolby Laboratories' CEO?

253 employees have rated Dolby Laboratories Chief Executive Officer Kevin J. Yeaman on Glassdoor.com. Kevin J. Yeaman has an approval rating of 84% among the company's employees.

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dolby Laboratories investors own include InterDigital (IDCC), Energy Transfer (ET), Advanced Micro Devices (AMD), AbbVie (ABBV), Abbott Laboratories (ABT), Bank of Hawaii (BOH), Mastercard (MA), STAG Industrial (STAG), Comcast (CMCSA) and NVIDIA (NVDA).

What is Dolby Laboratories' stock symbol?

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

How do I buy shares of Dolby Laboratories?

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dolby Laboratories' stock price today?

One share of DLB stock can currently be purchased for approximately $65.15.

How much money does Dolby Laboratories make?

Dolby Laboratories (NYSE:DLB) has a market capitalization of $6.57 billion and generates $1.28 billion in revenue each year. The electronics maker earns $310.23 million in net income (profit) each year or $1.94 on an earnings per share basis.

How many employees does Dolby Laboratories have?

The company employs 2,368 workers across the globe.

Does Dolby Laboratories have any subsidiaries?
The following companies are subsidiares of Dolby Laboratories: Coding Technologies, Dolby International AB, Dolby Laboratories Licensing Corporation, Doremi Labs, Step Labs, and Voxeet.
Read More
How can I contact Dolby Laboratories?

Dolby Laboratories' mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The official website for the company is www.dolby.com. The electronics maker can be reached via phone at (415) 558-0200, via email at investor@dolby.com, or via fax at 415-645-4000.

This page (NYSE:DLB) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.